Clinical Study of Shenhong Tongluo Recipe in Treating Carotid Atherosclerosis

[1] LU Chaoyang, YAO Yao, GUO Chunling. Research progress of PCSK9 and atherosclerosis[J]. Hainan Medical Science, 2022,33(4):504-508. Search in Google Scholar

[2] WANG Mengnan, QIN Hewei, GUO Ning, et al. Progress of next-generation probiotics against atherosclerosis[J]. Chinese Journal of Comparative Medicine,2022,32(12):95-102. Search in Google Scholar

[3] WANG Minghao,MENG Ying. Research progress on endoplasmic reticulum stress and atherosclerosis[J]. Journal of Microcirculation,2023,33(1):97-101. Search in Google Scholar

[4] Zhai Yi. Progress of anti-atherosclerosis research on gibberellic acid in the past 10 years[J]. Primary Chinese Medicine,2023,2(4):121-124. Search in Google Scholar

[5] Expert consensus on the prevention and treatment of atherosclerosis in Chinese and Western medicine (2021) [J]. Chinese Journal of Integrative Medicine and Western Medicine, 2022, 42(03): 287-293. Search in Google Scholar

[6] CHEN Ying, LI Song. Study on the pathological evolution of experimental “phlegm and stasis” model and the intervention effect of traditional Chinese medicine [J]. Journal of Changchun University of Traditional Chinese Medicine, 2013, 29(02): 336-7. Search in Google Scholar

[7] ZHOU Huadong, WANG Yanjiang, ZHANG Meng. Consensus on the diagnosis and treatment of head and neck atherosclerosis in China[J]. Chinese Journal of Neurology,2017,50(08):572-578. Search in Google Scholar

[8] Zheng Y. Guiding principles for clinical research of new Chinese medicines (for trial implementation) [M] Beijing: China Medical Science and Technology Press, 2002:73-77. Search in Google Scholar

[9] LI He, DU Yawei, WU Shengxian. Technical specifications for the design and evaluation of clinical randomized controlled trials of traditional Chinese medicine for the treatment of carotid atherosclerosis (version 2021)[J]. Journal of Traditional Chinese Medicine,2021,62(24):2204-2208.DOI:10.13288/j.11-2166/r.2021.24.016 Search in Google Scholar

[10] Whayne T F Jr.Prevention of Carotid Artery Atherosclerosis:What is the Evidence[J]. Angiology, 2017,68(8):661-668. Search in Google Scholar

[11] Wang X J,Li W Z,Song F J,et al.Carotid Atherosclerosis Detected by Ultrasonography:A National Cross-Sectional Study[J].J Am Heart Assoc,2018,7(8):e008701. Search in Google Scholar

[12] MEIM X D,CAO Y F,CHE Y Y,et al.Danshen:a phytoche-mical and pharmacological overview[J].Chin J Nat Med,2019,17(1):59. Search in Google Scholar

[13] Zhang J, Liu A, Hou R, et al.Salidroside protects cardiomyocyte against hypoxia-induced death:a HIF-1alpha-activated and VEGF-mediated pathway[J].Eur J Pharmacol, 2009, 607 (1-3) :6-14. Search in Google Scholar

[14] Li D, Fu Y, Zhang W, et al.Salidroside attenuates inflammatory responses by suppressing nuclear factor-kappa B and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice[J].Inflamm Res, 2013, 62 (1) :9-15. Search in Google Scholar

[15] Panossian A, Wikman G, Sarris J.Rosenroot (Rhodiola rosea) :traditional use, chemical composition, pharmacology and clinical efficacy[J].Phytomedicine, 2010, 17 (7) :481-493. Search in Google Scholar

[16] Liu Y R, Zhong H, Xu P B, et al. Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-Ms technoloavlJ1.Front Pharmacol. 2022,13:941400. Search in Google Scholar

[17] ZHANG Zhao; ZHANG Xinyi; ZHANG Meng; DU Meilin. Discussion on the identification and treatment of metabolic inflammation in type 2 diabetes mellitus from the theory of “endogenous heat and toxicity”[J]. Shandong Journal of Traditional Chinese Medicine, 2022, 41(09): 925-929. DOI: 10.16295/j.cnki.0257-358x.2022.09.002 Search in Google Scholar

[18] SHI Yan-Yu, QU Want-Tong, ZHANG Ze-Peng, et al. Mechanism of atherosclerosis prevention and treatment by regulating macrophage polarization with Senghong Tongluo Formula[J]. Chinese Journal of Gerontology,2022,42(14):3510-3514. Search in Google Scholar

[19] Lv Lina. Mechanism and clinical study on the action mechanism of Ginseng-Hong-Tongluo formula and active ingredients to improve myocardial ischemia-reperfusion injury[D]. Changchun University of Traditional Chinese Medicine,2022.DOI:10.26980/d.cnki.gcczc.2022.000051 Search in Google Scholar

[20] QIU Kui-Sen, LI Cai-Ming. Progress in the study of risk factors for fluctuating blood lipid levels and their relationship with ASCVD[J]. Modern Medicine and Health,2023,39(04):651-656. Search in Google Scholar

[21] LIANG Yun-yu, XIE Ping-chang, ZHONG Yan et al. Diagnostic efficacy of peripheral blood HCY, PLR and hs-CRP in predicting carotid atherosclerosis in patients with essential hypertension[J]. Advances in Modern Biomedicine,2021,21(16):3110-3114.DOI:10.13241/j.cnki. pmb.2021.16.023 Search in Google Scholar

[22] HUANG Cuifang, ZHAO Longbin, ZENG Qingyang et al. Correlation analysis of serum cystatin C, uric acid, homocysteine and carotid atherosclerotic plaque in patients with acute cerebral infarction[J]. Chinese Medical Science,2022,12(13):155-158. Search in Google Scholar

[23] LI Quan, SHEN Jianjiang, LI Pengfei. Diagnostic value of BNP, hscTnI combined with NLR and MLR in CKD combined with coronary heart disease[J]. Jiangsu Medicine,2023,49(10):985-988. DOI: 10.19460/j.cnki.0253-3685.2023.10.004 Search in Google Scholar